CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Aspirin, Clopidogreldrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00262275
NCT00262275N/ACompleted
CompareCT.gov

Optimum Platelet Inhibition After Coronary Artery Bypass Surgery: A Randomised Trial Comparing Platelet Aggregation Using Low, Medium Dose Aspirin and Clopidogrel

Papworth Hospital NHS Foundation Trust·interventional·Posted Dec 6, 2005·Updated Jan 22, 2016

In Brief

A clinical study evaluating Aspirin, Clopidogrel for Ischemic Heart Disease. Completed, across 1 site.

Detailed Summary

To investigate the effect of different dosages of aspirin on platelet aggregation and to determine the possible mechanisms of aspirin resistance, we intend to compare the effects of low, medium dose aspirin with clopidogrel (an alternative antiplatelet agent) in patients after coronary artery bypass surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIschemic Heart Disease
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 6, 2005
Enrollment StartJul 1, 2002
Primary CompletionJul 1, 2004
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 20.6 years ago

Interventions

Aspirin, Clopidogreldrug